No evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome

Pia Vahteristo, Taru A. Koski, Laura Naatsaari, Maija Kiuru, Auli Karhu, Riitta Herva, Satu-Leena Sallinen, Outi Vierimaa, Erik Bjorck, Stephane Richard, Betty Gardie, Didier Bessis, Emmanuel Van Glabeke, Ignacio Blanco, Richard Houlston, Leigha Senter, Marja Hietala, Kristiina Aittomaki, Lauri A. Aaltonen, Virpi LaunonenRainer Lehtonen

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalFamilial Cancer
Volume9
Pages (from-to)245-251
Number of pages7
ISSN1389-9600
DOIs
Publication statusPublished - 2010
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Fumarate hydratase
  • Genetic testing
  • HLRCC
  • Modifier
  • Renal cell cancer
  • FUMARATE HYDRATASE MUTATIONS
  • HEREDITARY LEIOMYOMATOSIS
  • UTERINE LEIOMYOMATOSIS
  • CUTANEOUS LEIOMYOMATOSIS
  • MISSENSE MUTATIONS
  • CLINICAL-FEATURES
  • TUMOR SYNDROME
  • FH
  • PARAGANGLIOMA
  • DEFICIENCY

Cite this